CNR Institutional Research Information System

GAGGINI, MELANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.906
NA - Nord America 1.091
EU - Europa 585
SA - Sud America 366
AF - Africa 35
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 3.987
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.036
SG - Singapore 681
CN - Cina 452
BR - Brasile 292
IT - Italia 261
VN - Vietnam 215
HK - Hong Kong 205
JP - Giappone 84
FR - Francia 83
BD - Bangladesh 75
KR - Corea 72
FI - Finlandia 41
NL - Olanda 39
DE - Germania 33
GB - Regno Unito 31
AR - Argentina 28
CA - Canada 25
IN - India 25
EC - Ecuador 20
ID - Indonesia 17
MX - Messico 17
IQ - Iraq 15
ES - Italia 13
IE - Irlanda 12
SA - Arabia Saudita 10
ZA - Sudafrica 10
AT - Austria 9
IL - Israele 9
MA - Marocco 9
PL - Polonia 9
RU - Federazione Russa 8
SE - Svezia 7
TR - Turchia 7
LT - Lituania 6
PE - Perù 6
CO - Colombia 5
TN - Tunisia 5
UA - Ucraina 5
VE - Venezuela 5
CL - Cile 4
DK - Danimarca 4
HN - Honduras 4
RO - Romania 4
TW - Taiwan 4
BH - Bahrain 3
CH - Svizzera 3
EE - Estonia 3
EG - Egitto 3
JO - Giordania 3
KZ - Kazakistan 3
LB - Libano 3
PH - Filippine 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BS - Bahamas 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
GE - Georgia 2
LK - Sri Lanka 2
PK - Pakistan 2
PT - Portogallo 2
PY - Paraguay 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
UZ - Uzbekistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BO - Bolivia 1
BW - Botswana 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
MD - Moldavia 1
ML - Mali 1
MY - Malesia 1
NA - Namibia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
SI - Slovenia 1
SV - El Salvador 1
TJ - Tagikistan 1
TM - Turkmenistan 1
VG - Isole Vergini Britanniche 1
ZW - Zimbabwe 1
Totale 3.987
Salva come PNG Salva come JPEG
Città #
Singapore 423
Hong Kong 202
Santa Clara 202
Hefei 164
San Jose 147
Ashburn 105
Beijing 97
Los Angeles 83
Lauterbourg 74
Tokyo 73
Seoul 70
Ho Chi Minh City 66
Hanoi 59
Cascina 51
Pisa 43
New York 38
Dallas 35
São Paulo 34
Lappeenranta 21
Council Bluffs 19
Buffalo 18
Orem 16
Frankfurt am Main 15
Florence 14
Helsinki 14
Amsterdam 13
Rio de Janeiro 13
Dublin 12
Milan 12
Brooklyn 11
Denver 10
Atlanta 9
Chicago 9
Da Nang 9
Minamishinagawa 9
Naples 9
Phoenix 9
Quito 9
Rome 9
Vienna 9
Warsaw 9
Boston 8
City of London 8
Houston 8
Hải Dương 8
Montreal 8
Belo Horizonte 7
Charlotte 7
Fortaleza 7
Haiphong 7
Stockholm 7
Bengaluru 6
Campinas 6
Guayaquil 6
Lima 6
London 6
Lucca 6
Toronto 6
Turku 6
Biên Hòa 5
Buenos Aires 5
Changsha 5
Guangzhou 5
Madrid 5
Vũng Tàu 5
Baghdad 4
Belém 4
Boardman 4
Bologna 4
Chennai 4
Curitiba 4
Düsseldorf 4
Falkenstein 4
Ha Long 4
Mexico City 4
Mumbai 4
Munich 4
Poplar 4
Ribeirão Preto 4
San Francisco 4
Vilnius 4
Altamura 3
Amman 3
Ankara 3
Bari 3
Brasília 3
Bắc Giang 3
Fort Worth 3
Hangzhou 3
Iesi 3
Jackson 3
Jakarta 3
Jeddah 3
Johannesburg 3
Kyiv 3
Lấp Vò 3
Marseille 3
Milwaukee 3
Modena 3
Mosul 3
Totale 2.518
Salva come PNG Salva come JPEG
Nome #
Subjects with non alcoholic fatty liver disease (NAFLD) display increased visceral and pancreatic fat associated with worse metabolic profile 198
Metabolic Syndrome, Thyroid Dysfunction, and Cardiovascular Risk: The Triptych of Evil 155
Fatty Liver Index (FLI) Identifies Not Only Individuals with Liver Steatosis but Also at High Cardiometabolic Risk 100
Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance 94
Lipids in Atherosclerosis: Pathophysiology and the Role of Calculated Lipid Indices in Assessing Cardiovascular Risk in Patients with Hyperlipidemia 91
Vitamin D Determinants, Status, and Antioxidant/ Antiinflammatory-Related Effects in Cardiovascular Risk and Disease: Not the LastWord in the Controversy 90
The Thyroid-Oxidative Stress Axis in Heart Failure 89
New Molecules in Type 2 Diabetes: Advancements, Challenges and Future Directions 78
Changes in plasma bioactive lipids and inflammatory markers during a half-marathon in trained athletes 76
The Nonalcoholic Steatohepatitis Metabotype: Imbalance of Circulating Amino Acids and Transamination Reactions Reflect Impaired Mitochondrial Function REPLY 73
Ceramides as mediators of oxidative stress and inflammation in cardiometabolic disease 71
FIB-4 Index and Neutrophil-to-Lymphocyte-Ratio as Death Predictor in Coronary Artery Disease Patients 67
Lipoprotein(a), Cardiovascular Events and Sex Differences: A Single Cardiological Unit Experience 66
Lipidomic analysis to assess the correlation between ceramides, stress hyperglycemia, and HbA1c in acute myocardial infarction 64
Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals 63
Concordance between indirect fibrosis and steatosis indices and their predictors in subjects with overweight/obesity 60
PPAR-γ-induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH 60
Casi d’Uso per APP eSDL: Aggiunta nuovi Locali Aggiornamento Procedure di Servizio SSPR IFC-CNR 60
Oxidative stress biomarkers in the relationship between type 2 diabetes and air pollution 60
Biomonitoring of Bis(2-ethylhexyl)phthalate (DEHP) in Italian children and adolescents: Data from LIFE PERSUADED project 59
Angiopoietin like protein 4 (ANGPTL4): a marker of alteration in lipid metabolism, insulin resistance and ectopic fat accumulation 59
Increased hepatic glucose production and insulin resistance are associated to increased plasma concentrations of glucogenic amino acids in subjects with NAFLD 58
Interplay between Oxidative Stress and Metabolic Derangements in Non-Alcoholic Fatty Liver Disease: The Role of Selenoprotein P 58
LACK OF NLRP3-INFLAMMASOME LEADS TO GUT-LIVER AXIS DERANGEMENT AND INCREASES HEPATIC INJURY IN A MOUSE MODEL OF NON-ALCOHOLIC FATTY LIVER DISEASE 57
Data mining of key genes expression in hepatocellular carcinoma: novel potential biomarkers of diagnosis prognosis or progression 57
Expression profile of adrenomedullin and its specific receptors in liver tissues from patients with hepatocellular carcinoma and in tumorigenic cell line-secreted extracellular vesicles 56
Ceramides and Cardiovascular Risk Factors, Inflammatory Parameters and Left Ventricular Function in AMI Patients 56
Comparison between galectin-3 and YKL-40 levels for the assessment of liver fibrosis in cirrhotic patients 56
Advanced glycation end products, leukocyte telomere length, and mitochondrial DNA copy number in patients with coronary artery disease and alterations of glucose homeostasis: From the GENOCOR study 54
H2S as a Bridge Linking Inflammation, Oxidative Stress and Endothelial Biology: A Possible Defense in the Fight against SARS-CoV-2 Infection? 53
Systemic Immune-Inflammation Index and Systemic Inflammatory Response Index as Predictors of Mortality in ST-Elevation Myocardial Infarction 53
Evaluation of published clinical scores for the prediction of cardiometabolic risk in the SEMEOTICONS project 53
Inflammatory Biomarkers are Correlated with Some Forms of Regressive Autism Spectrum Disorder 51
Exenatide improves both hepatic and adipose tissue insulin resistance: A dynamic positron emission tomography study 51
Sphingolipid Levels and Signaling via Resveratrol and Antioxidant Actions in Cardiometabolic Risk and Disease 51
Mechanisms for increased risk of diabetes in chronic liver diseases 50
Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests 49
Crosstalk between Irisin Levels, Liver Fibrogenesis and Liver Damage in Non-Obese, Non-Diabetic Individuals with Non-Alcoholic Fatty Liver Disease 49
Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease 48
Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease 48
Altered metabolic profile and adipocyte insulin resistance mark severe liver fibrosis in patients with chronic liver disease 47
EVALUATION OF METABOLIC PARAMETERS OF HEPATIC DYSFUNCTION IN SUBJECTS WITH HEPATOCELLULAR CARCINOMA AND THEIR CHANGE AFTER LIVER TRANSPLANTATION: A METABOLOMIC APPROACH 46
Osteoprotegerin as a marker of atherosclerosis and severity of CAD in patients candidate to cardiac imaging. 45
Brown versus white fat: are they really playing a role in obesity and cardiometabolic risk? "Brown adipose tissue plays a key role in thermogenesis..." 45
Interplay between Vitamin D and Sphingolipids in Cardiometabolic Diseases 45
Plasma Ceramides Pathophysiology, Measurements, Challenges, and Opportunities 45
Cardiometabolic risk and subclinical vascular damage assessment in idiopathic inflammatory myopathies: a challenge for the clinician 45
Do pentraxin 3 and neural pentraxin 2 have different facet function in hepatocellular carcinoma? 44
The Dark Triad of Particulate Matter, Oxidative Stress and Coronary Artery Disease: What About the Antioxidant Therapeutic Potential 43
Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease 41
Effects of Probiotic Supplementationon Gastrointestinal, Sensory and Core Symptoms in Autism Spectrum Disorders: A Randomized Controlled Trial 41
The Sphingolipid-Signaling Pathway as a Modulator of Infection by SARS-CoV-2 41
Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD (vol 7, 12200, 2017) 41
Hepatic macrophage activation is associated with adipose tissue insulin resistance in non-diabetic patients with Non-Alcoholic Fatty Liver Disease 41
Vitamin D and Ceramide Metabolomic Profile in Acute Myocardial Infarction 39
Small intestinal metabolism is central to whole-body insulin resistance 38
Glucose metabolism in high-risk subjects for type 2 diabetes carrying the rs7903146 TCF7L2 gene variant 36
Lipids Metabolism and Cardiometabolic Diseases 36
Insulin resistance and cardiometabolic indexes: comparison of concordance in working-age subjects with overweight and obesity 35
Increased lipotoxicity and insulin resistance in non diabetic patients with hepatocellular carcinoma 34
Type 2 Diabetes and Oxidative Stress and Inflammation: Pathophysiological Mechanisms and Possible Therapeutic Options 34
Assessment of RANKL/RANK/osteoprotegerin system expression in patients with hepatocellular carcinoma. 33
Squadra di Emergenza - APP per il Rapporto Periodico dei presidi Antincendio - NewSE v1.2 32
The subtle balance between lipolysis and lipogenesis: A critical point in metabolic homeostasis 32
Pericardial fat but not calcium score correlates with oxidative products in patients with known coronary artery disease 32
Evaluation of Apelin/APJ system expression in hepatocellular carcinoma as a function of clinical severity 31
HCC Development Is Associated to Peripheral Insulin Resistance in a Mouse Model of NASH 30
Glucose kinetics: an update and novel insights into its regulation by glucagon and GLP-1. 29
Increased FNDC5/Irisin expression in human hepatocellular carcinoma 29
Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease 29
Saturated fat is more metabolically harmful for the human liver than unsaturated fat or simple sugars 29
Conventional and innovative methods to assess oxidative stress biomarkers in the clinical cardiovascular setting 28
Insulin resistance and endothelial dysfunction: a mutual relationship in cardiometabolic risk 28
Angiopoietin-Like Protein 4 Overexpression in Visceral Adipose Tissue from Obese Subjects with Impaired Glucose Metabolism and Relationship with Lipoprotein Lipase 28
Relationship between hepatic and systemic angiopoietin-like 3, hepatic Vitamin D receptor expression and NAFLD in obesity 27
Insights into the Roles of GLP-1, DPP-4, and SGLT2 at the Crossroads of Cardiovascular, Renal, and Metabolic Pathophysiology 25
Nonalcoholic Fatty Liver Disease and Type 2 Diabetes: Common Pathophysiologic Mechanisms 24
Ectopic fat: a target for cardiometabolic risk management 24
A 2,3-diphenylpyrido[1,2-a] pyrimidin-4-one derivative inhibits specific angiogenic factors induced by TNF-? 23
Osteopontin in hepatocellular carcinoma: A possible biomarker for diagnosis and follow-up 23
Role of Adipose Tissue Insulin Resistance in the Natural History of Type 2 Diabetes: Results From the San Antonio Metabolism Study. 22
Osteoprotegerin as optimal target for the screening of patients with hepatocellular carcinoma at higher risk of mortality 22
The color of fat and its central role in the development and progression of metabolic diseases 22
Chronic intranasal insulin does not affect hepatic lipids but lowers circulating BCAAs in healthy male subjects 21
Ectopic fat: the true culprit linking obesity and cardiovascular disease? 18
Totale 4.244
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.844
article - articoli 13.308
book - libri 209
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.361
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202480 0 0 0 0 0 0 0 0 30 19 16 15
2024/20251.382 25 13 102 102 267 59 48 96 62 56 320 232
2025/20262.777 110 354 172 402 474 140 321 140 184 181 173 126
2026/20275 5 0 0 0 0 0 0 0 0 0 0 0
Totale 4.244